Surgery Partners (SGRY) Receivables (2016 - 2025)
Surgery Partners (SGRY) has disclosed Receivables for 12 consecutive years, with $602.2 million as the latest value for Q4 2025.
- Quarterly Receivables rose 3.99% to $602.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $602.2 million through Dec 2025, up 3.99% year-over-year, with the annual reading at $602.2 million for FY2025, 3.99% up from the prior year.
- Receivables hit $602.2 million in Q4 2025 for Surgery Partners, up from $579.3 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $602.2 million in Q4 2025 to a low of $367.0 million in Q1 2021.
- Historically, Receivables has averaged $479.3 million across 5 years, with a median of $459.6 million in 2022.
- Biggest five-year swings in Receivables: increased 20.59% in 2021 and later increased 3.99% in 2025.
- Year by year, Receivables stood at $430.2 million in 2021, then grew by 6.07% to $456.3 million in 2022, then grew by 8.79% to $496.4 million in 2023, then grew by 16.66% to $579.1 million in 2024, then rose by 3.99% to $602.2 million in 2025.
- Business Quant data shows Receivables for SGRY at $602.2 million in Q4 2025, $579.3 million in Q3 2025, and $563.1 million in Q2 2025.